Both oral and poster presentations focused on our recent novel findings about a connection between polycystic ovaries (PCO) and specific angiogenic growth factors that may be responsible for the increased risk of ovarian hyperstimulation syndrome (OHSS) that occurs when women with PCO receive fertility medications. These novel findings may one day help us learn how to reduce the risk of ovarian hyperstimulation, a well known complication of women who have PCO when undergoing fertility treatments. Authors of the studies included: Reshef Tal MD PhD, David Seifer MD, Aya Shohat-Tal PhD, Richard Grazi MD and Henry Malter PhD.
More from Fertility Health

How safe are your frozen eggs and embryos?
Taking steps to preserve fertility for men and women is important to the physicians and staff at GENESIS. To set…
Read More
How safe are your frozen eggs and embryos?
Read More

What to know about insurance and infertility
If you are planning to seek infertility treatment, you are no doubt concerned about affording treatment. Many couples handle the…
Read More
What to know about insurance and infertility
Read More

Can Probiotics Boost Fertility?
Whether you are trying to conceive for the first time or are seeking professional help after a year or even…
Read More
Can Probiotics Boost Fertility?
Read More